Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2025 08:01 ET | Source: Mainz BioMed NV

Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)

Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)
October 15, 2025 09:01 ET | Source: Mainz BioMed NV

Mainz Biomed to Attend 2025 Maxim Growth Summit

Mainz Biomed N.V. to Attend 2025 Maxim Growth Summit
October 08, 2025 09:00 ET | Source: Mainz BioMed NV

Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

Mainz Biomed Reports Topline Results Pancreatic Study - Study Demonstrated a Sensitivity of 100% and Specificity of 95%
September 30, 2025 08:01 ET | Source: Mainz BioMed NV

Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting

Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting
September 23, 2025 08:01 ET | Source: Mainz BioMed NV

Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland

Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland
September 02, 2025 08:01 ET | Source: Mainz BioMed NV

Mainz Biomed Announces Registration of ColoAlert in the United Kingdom

Mainz Biomed Announces Registration of ColoAlert in the United Kingdom
August 13, 2025 08:01 ET | Source: Mainz BioMed NV

Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®

Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®
August 04, 2025 10:22 ET | Source: Mainz BioMed NV

Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants

Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants
July 23, 2025 08:01 ET | Source: Mainz BioMed NV

Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies

Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies
July 15, 2025 08:01 ET | Source: Mainz BioMed NV

Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition

MYNZ Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition